Kent Imaging Partners with Healthliant Ventures to Pilot SnapshotNIR at Tanner Health
Kent Imaging is proud to announce a new partnership with Healthliant Ventures, the innovation arm of Tanner Health, to bring real-time tissue oxygenation imaging into clinical workflows using the SnapshotNIR device.
This two-phase pilot project will demonstrate how SnapshotNIR enhances wound care and clinical decision-making, with future integration into Epic’s EHR system to streamline documentation and improve patient outcomes.
“We’re excited to partner with Healthliant Ventures and Tanner Health to bring the power of SnapshotNIR into the clinical environment,” said Pierre Lemire, CEO of Kent Imaging. “This collaboration highlights how real-time tissue oxygenation imaging can be embedded into existing workflows to support more informed, ethical and efficient care. By delivering objective data directly into the EHR, we’re enabling clinicians to justify treatments, document decisions accurately and ultimately improve patient outcomes.”
“Partnering with Kent Imaging on SnapshotNIR illustrates our commitment to bringing advanced imaging technologies into everyday clinical practice,” said Steve West, managing director of Healthliant Ventures. “This pilot underscores our ability to deepen clinical workflows, help clinicians access better data and ultimately deliver improved patient outcomes.”
Visit Healthliant Ventures and read the press release to learn more about this exciting collaboration.
About Kent Imaging
Based in Calgary, Alberta, Canada, Kent Imaging is a leading innovator in advanced diagnostic imaging technology. The company designs, manufactures, and markets medical devices that support real-time decision-making in wound care, vascular, and surgical specialties. Through patented technologies, Kent continues to deliver groundbreaking solutions that support healthcare systems around the world.
The Snapshot product suite now includes two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017 and CE-marked in 2025; and SnapshotGLO, a bacterial autofluorescence imaging device that received FDA 510(k) clearance in 2025. SnapshotNIR is supported by clinical evidence demonstrating its role in enhancing clinical decision-making, while SnapshotGLO provides real-time insight into wound bioburden presence and distribution. Together, the Snapshot product family strengthens clinicians’ ability to detect, direct, and protect—promoting treatment consistency, supporting improved workflow, and contributing to better patient care worldwide.
About Healthliant Ventures
Healthliant Ventures was born out of the idea of Tanner Health being a strategic partner to healthcare startups seeking to validate their products or services, expand their offerings through co-development and market them to other health systems and types of customers. Healthliant Ventures is dedicated to driving innovation, fostering strategic partnerships and transforming the way health care is delivered. Committed to advancing the industry, Healthliant Ventures focuses on developing innovative technologies and driving impactful change across the healthcare landscape.
Learn more at healthliant.com.
About Tanner Health
Tanner Health is a five-hospital non-profit health system providing convenient, personalized health care to communities across west Georgia and east Alabama. Tanner Health physicians and staff provide the latest technology and treatment options to advance the health of its patients. In addition to its regional hospitals and care centers, Tanner operates Tanner Medical Group, one of metro Atlanta’s largest multi-specialty physician groups.
Learn more at tanner.org.